Pulmocide presents clinical update from promising antifungal program at 2019 Respiratory Innovation Summit Pulmocide presents clinical update from promising antifungal program at 2019 Respiratory Innovation Summit London, UK; 17 May 2019 – Pulmocide Ltd, which is developing first-in-class inhaled...